HL-051

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameHL-051
Drug Alias Nameamlodipine besylate + irbesartan (HanAll)irbesartan + amlodipine besylate (HanAll)HL-051 XC
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockersAngiotensin II Receptor Type 1 antagonists
TargetsVoltage-gated calcium channelAngiotensin II Receptor Type 1
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHanAll Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHanAll Biopharma Co Ltd
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A